ARCHIVES

Carcinogenesis Testing To Stay In NCI, But Control Will Go To New Group Headed By Rall

This article is from The Cancer Letter archive.

Vol. 04 No. 37 | September 15, 1978

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

ACS Board Approves Special Donors Concept, Oks New Program or Cause And Prevention Research

February 23, 1979

Local University Competing for Part FCRF Contract

December 4, 1981

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

November 16, 2001

Two Doses of the Vaccine Cervarix Can Be As Effective As Three

September 30, 2011

NCI Cooperative Group Clinical Trials Listed

April 24, 2009